These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7235011)

  • 1. Renal and systemic acid-base effects of chronic spironolactone administration.
    Hulter HN; Bonner EL; Glynn RD; Sebastian A
    Am J Physiol; 1981 May; 240(5):F381-7. PubMed ID: 7235011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired renal H+ secretion and NH3 production in mineralocorticoid-deficient glucocorticoid-replete dogs.
    Hulter HN; Ilnicki LP; Harbottle JA; Sebastian A
    Am J Physiol; 1977 Feb; 232(2):F136-46. PubMed ID: 14506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acid-base and endocrine effects of aldosterone and angiotensin II inhibition in metabolic acidosis in human patients.
    Henger A; Tutt P; Riesen WF; Hulter HN; Krapf R
    J Lab Clin Med; 2000 Nov; 136(5):379-89. PubMed ID: 11079465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of glucocorticoid steroids on renal and systemic acid-base metabolism.
    Hulter HN; Licht JH; Bonner EL; Glynn RD; Sebastian A
    Am J Physiol; 1980 Jul; 239(1):F30-43. PubMed ID: 7395993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of mineralocorticoid replacement therapy on renal acid-base homeostasis in adrenalectomized patients.
    Sebastian A; Sutton JM; Hulter HN; Schambelan M; Poler SM
    Kidney Int; 1980 Dec; 18(6):762-73. PubMed ID: 7206460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azolimine: a nonsteroidal antagonist of the effects of mineralocorticoids on renal electrolyte excretion.
    Gussin RZ; Ronsberg MA; Stokey EH; Cummings JR
    J Pharmacol Exp Ther; 1975 Oct; 195(1):8-15. PubMed ID: 1181406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestogens with antimineralocorticoid activity.
    Losert W; Casals-Stenzel J; Buse M
    Arzneimittelforschung; 1985; 35(2):459-71. PubMed ID: 4039568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure.
    van den Berg DT; de Kloet ER; van Dijken HH; de Jong W
    Endocrinology; 1990 Jan; 126(1):118-24. PubMed ID: 2293978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acute mineralocorticoid and glucocorticoid receptor blockade on the excretion of an acute potassium load in healthy humans.
    van Buren M; Boer P; Koomans HA
    J Clin Endocrinol Metab; 1993 Oct; 77(4):902-9. PubMed ID: 8408463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The critical role of the adrenal gland in the renal regulation of acid-base equilibrium during chronic hypotonic expansion. Evidence that chronic hyponatremia is a potent stimulus to aldosterone secretion.
    Cohen JJ; Hulter HN; Smithline N; Melby JC; Schwartz WB
    J Clin Invest; 1976 Nov; 58(5):1201-8. PubMed ID: 993340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of growth hormone on renal and systemic acid-base homeostasis in humans.
    Sicuro A; Mahlbacher K; Hulter HN; Krapf R
    Am J Physiol; 1998 Apr; 274(4):F650-7. PubMed ID: 9575887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal acidification in patients with mineralocorticoid deficiency.
    Perez GO; Oster JR; Vaamonde CA
    Nephron; 1976; 17(6):461-73. PubMed ID: 796742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of extracellular fluid volume depletion on renal regulation of acid-base and potassium equilibrium during prolonged mineral acid administration.
    Hulter HN; Toto RD; Sebastian A; Mackie S; Cooke CR; Wilson TE; Melby JC
    J Lab Clin Med; 1984 Jun; 103(6):854-68. PubMed ID: 6726056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralo- and glucocorticoid effects on renal excretion of electrolytes.
    Campen TJ; Vaughn DA; Fanestil DD
    Pflugers Arch; 1983 Oct; 399(2):93-101. PubMed ID: 6647008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of mineralocorticoids on acid-base balance.
    Wagner CA
    Nephron Physiol; 2014; 128(1-2):26-34. PubMed ID: 25377117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal acidosis in mineralocorticoid deficiency is not dependent on NaCl depletion or hyperkalemia.
    Hulter HN; Licht JH; Glynn RD; Sebastian A
    Am J Physiol; 1979 Mar; 236(3):F283-94. PubMed ID: 34326
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal and systemic acid-base effects of chronic dichloroacetate administration in dogs.
    Hulter HN; Glynn RD; Sebastian A
    Metabolism; 1980 Oct; 29(10):997-1002. PubMed ID: 7421587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of renal hyperchloremic acidosis resulting from dietary potassium restriction in the dog: role of aldosterone.
    Hulter HN; Sebastian A; Sigala JF; Licht JH; Glynn RD; Schambelan M; Biglieri EG
    Am J Physiol; 1980 Feb; 238(2):F79-91. PubMed ID: 7361893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective effect of mineralocorticoid replacement therapy on renal acid excretion in congenital adrenal hyperplasia.
    Simón J; Mendizabal S; Martinez F; Carles C; Zamora I
    Acta Paediatr Scand; 1990; 79(6-7):652-7. PubMed ID: 2386057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoids have a role in renal cortical expression of the SNAT3 glutamine transporter during chronic metabolic acidosis.
    Karinch AM; Lin CM; Meng Q; Pan M; Souba WW
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F448-55. PubMed ID: 16954343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.